Skip to main content
Clinical Trials/NCT02288715
NCT02288715
Completed
Not Applicable

Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy

Kang Yan1 site in 1 country110 target enrollmentMay 2014
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Kang Yan
Enrollment
110
Locations
1
Primary Endpoint
relationship between cerebral perfusion pressure variability and sepsis-associated encephalopathy
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of the study is to evaluate whether variability of CPP (cerebral perfusion pressure) is related to sepsis-associated encephalopathy and outcomes of patients with sepsis.

Detailed Description

Encephalopathy is a common complication of sepsis, impaired cerebrovascular autoregulation (AR) in patients with sepsis is considered related to Sepsis-associated encephalopathy (SAE). As AR is important in stabilizing the cerebral perfusion pressure, whether greater variability of CPP is related to SAE and mortality or not remains unclear. We conduct this study to evaluate the relationship between them.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
March 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kang Yan
Responsible Party
Sponsor Investigator
Principal Investigator

Kang Yan

Director of Intensive Care Unit

West China Hospital

Eligibility Criteria

Inclusion Criteria

  • clinical symptoms of sepsis, severe sepsis and septic shock
  • age over 18 years

Exclusion Criteria

  • preexisting Neurological diseases
  • traumatic brain injury
  • intracranial infectious disease
  • severe hepatic or renal dysfunction
  • ICU discharge Within 72 hours
  • pregnancy

Outcomes

Primary Outcomes

relationship between cerebral perfusion pressure variability and sepsis-associated encephalopathy

Time Frame: cerebral perfusion pressure is assessed up to 72 hours

To estimate CPP noninvasively, we will monitor the middle cerebral artery flow velocity of patients with sepsis using transcranial Doppler ultrasound in the first 72h of their enrollment. Diagnosis of a SAE was performed using the confusion assessment method for ICU(CAM-ICU).

Secondary Outcomes

  • Time of hospital stay(All the participants will be followed up until discharge or death, assessed up to 24 months)
  • 90-day mortality rate(All the participants will be followed up until 90 days after their enrollment or death)
  • Duration of mechanical ventilation(All the participants will be followed up until discharge or death, assessed up to 24 months)
  • Time of ICU stay(All the participants will be followed up until discharge or death, assessed up to 24 months)
  • 2-year quality of life of survivors(All the participants will be followed up until 2 year after their enrollment or death)
  • 1-year mortality rate(All the participants will be followed up until 1 year after their enrollment or death)
  • 2-year mortality rate(All the participants will be followed up until 2 years after their enrollment or death)
  • 1-year quality of life of survivors(All the participants will be followed up until 1 year after their enrollment or death)

Study Sites (1)

Loading locations...

Similar Trials